1. Evaluation of 131/123I-5-iodo-2′-deoxycytidine as a novel proliferation probe in a tumor mouse model
- Author
-
Chih Chieh Shen, Chuan Lin Chen, Wei Ti Kuo, Chih-Yuan Lin, Pei Chia Chan, Chun Yi Wu, Ren Shan Liu, Wen Yi Chang, and Hsin Ell Wang
- Subjects
Biodistribution ,Metabolic Clearance Rate ,Molecular Probe Techniques ,Deoxycytidine ,Iodine Radioisotopes ,Mice ,chemistry.chemical_compound ,In vivo ,Cell Line, Tumor ,Iodine-123 ,Animals ,Tissue Distribution ,Radionuclide Imaging ,Radiation ,Sarcoma ,Bromodeoxycytidine ,Deoxyuridine ,Imaging agent ,Biochemistry ,chemistry ,Organ Specificity ,Cell culture ,Isotope Labeling ,Cancer research ,Female ,Biological half-life ,Radiopharmaceuticals - Abstract
This study evaluated a radioiodinated deoxycytidine analog, (131)I-5-iodo-2'-deoxycytidine ([(131)I]ICdR), as a novel proliferation probe and compared it with (131)I-5-iodo-2'-deoxyuridine ([(131)I]IUdR) in a NG4TL4 sarcoma-bearing mouse model. As an imaging agent, the biological characteristics of [(123)I]IUdR is not satisfactory due to its metabolic instability and short biological half-life in vivo. With [(123)I]ICdR/SPECT it was possible to clearly delineate the tumor lesion at 1h post-injection (tumor-to-muscle ratio 7.74) in tumor-bearing mice. The results of biodistribution were consistent with those observed in scintigraphic imaging. This study demonstrated that [(131)I]ICdR is a more promising SPECT probe than [(131)I]IUdR for imaging proliferation.
- Published
- 2013
- Full Text
- View/download PDF